Ketorolac (injection)

🧮 Dose calculator

Mild to moderate pain · Regimen source: FDA Ketorolac inj. · Dosage and Administration

• • ≥65 y, renal impairment or <50 kg: 30 mg IM. IV: 30 mg (or 15 mg in those groups). FDA Ketorolac inj. · Dosage and Administration

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Ketorolac inj. · Precautions/Warnings – Pregnancy

  “Clinical Considerations Fetal/Neonatal Adverse Reactions Premature Closure of Fetal Ductus Arteriosus: Avoid use of NSAIDs in women at about 30 weeks gestation and later in pregnancy, because NSAIDs, including ketorolac tromethamine, can cause premature closure of the fetal ductus arteriosus (see WARNINGS;”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Ketorolac inj. · Precautions/Warnings – Nursing Mothers

  “Limited data from one published study that included 10 breastfeeding women 2-6 days postpartum showed low levels of ketorolac in breast milk and were undetectable (less than 5 ng/mL) in 4 of the patients.”

• 👶 ChildrenDangerous / avoid

  Boxed warning in the label about children. FDA Ketorolac inj. · Boxed Warning

  “Ketorolac tromethamine is not indicated for use in pediatric patients and it is NOT indicated for minor or chronic painful conditions.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ketorolac inj. · Boxed Warning

  “Elderly patients are at greater risk for serious gastrointestinal events (see WARNINGS ).”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.